title: Prasugrel and cancer.
authors.forename: Marco
authors.initials: M
authors.lastname: Cattaneo
mesh_terms: D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced*; D010879:Piperazines / Q000009:adverse effects*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D000068799:Prasugrel Hydrochloride; D058919:Purinergic P2 Receptor Antagonists / Q000009:adverse effects*; D058925:Receptors, Purinergic P2Y12; D013876:Thiophenes / Q000009:adverse effects*; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives
chemical_list: D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D058919:Purinergic P2 Receptor Antagonists; D058925:Receptors, Purinergic P2Y12; D013876:Thiophenes; D000077144:Clopidogrel; D000068799:Prasugrel Hydrochloride; D013988:Ticlopidine